Introduction
The insecticidal bacterium Bacillus thuringiensis is a grampositive aerobic spore-former found in many environmental niches [30] . This species is distinguished from other Bacillus species by the synthesis of crystalline inclusions that typically contain insecticidal proteins known as Cry (crystal) and Cyt (cytolytic) protoxins. Upon ingestion by a larval host, these protoxins dissolve in the midgut lumen, where they are cleaved by proteases to yield active toxins. The toxins then bind to microvillar receptors, forming cation channels that cause lysis of midgut epithelial cells, which erode from the epithelium, resulting in larval death [2, 3, 6, 7, 14, 19, 32] . The target spectrum of an isolate depends primarily on its complement of Cry and Cyt proteins. Cry1 and Cry3 toxins, for example, are active against, respectively, lepidopterans and coleopterans, whereas Cry4A, Cry4B, and Cry11A are toxic to nematoceran dipterans, which notably include many mosquito and blackfly vectors of important human diseases such as malaria, yellow fever, and filariasis [6, 7, 27, 28] . Cry2Aa, unlike other Cry proteins, is unusual in that its target spectrum includes both lepidopteran and The Cyt1Aa protein of Bacillus thuringiensis susbp. israelensis elaborates demonstrable toxicity to mosquito larvae, but more importantly, it enhances the larvicidal activity of this species Cry proteins (Cry11Aa, Cry4Aa, and Cry4Ba) and delays the phenotypic expression of resistance to these that has evolved in Culex quinquefasciatus. It is also known that Cyt1Aa, which is highly lipophilic, synergizes Cry11Aa by functioning as a surrogate membrane-bound receptor for the latter protein. Little is known, however, about whether Cyt1Aa can interact similarly with other Cry proteins not primarily mosquitocidal; for example, Cry2Aa, which is active against lepidopteran larvae, but essentially inactive or has very low toxicity to mosquito larvae. Here we demonstrate by ligand binding and enzyme-linked immunosorbent assays that Cyt1Aa and Cry2Aa form intermolecular complexes in vitro, and in addition show that Cyt1Aa facilitates binding of Cry2Aa throughout the midgut of C. quinquefasciatus larvae. As Cry2Aa and Cry11Aa share structural similarity in domain II, the interaction between Cyt1Aa and Cry2Aa could be a result of a similar mechanism previously proposed for Cry11Aa and Cyt1Aa. Finally, despite the observed interaction between Cry2Aa and Cyt1Aa, only a 2-fold enhancement in toxicity resulted against C. quinquefasciatus. Regardless, our results suggest that Cry2Aa could be a useful component of mosquitocidal endotoxin complements being developed for recombinant strains of B. thuringiensis subsp. israelensis and B. sphaericus aimed at improving the efficacy of commercial products and avoiding resistance.
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dipteran larvae [34] . Compared with Cry11A, Cry4A, and Cry4B, however, the toxicity of Cry2Aa against mosquito larvae is very low, being at least 10-fold less toxic than the former three proteins [21, 33] . Alternatively, Cyt1Aa, which is not related to Cry toxins, is moderately toxic to dipterans and certain coleopterans, but is not toxic to lepidopterans [20] .
The most potent subspecies of B. thuringiensis active against mosquito larvae is B. thuringiensis subsp. israelensis. Its high toxicity is due to a combination of toxins, mainly Cry11Aa, Cry4Aa, Cry4Ba, and Cyt1Aa [7] . These occur together in a large parasporal body enveloped in a fibrous matrix, yielding high toxicity and a broad target host range, a structural combination that appears to have been selected for during evolution [13, 5] . Moreover, Cyt1Aa synergizes Cry4Aa, Cry4Ba, and Cry11Aa toxicity and delays the evolution of resistance to Cry11Aa [4, 26, 31, 36, 37, 38] . After decades of use in mosquito and blackfly abatement programs, no significant resistance to date has evolved to B. thuringiensis subsp. israelensis, with a primary reason apparently being its unique parasporal body.
More potent recombinant strains of B. thuringiensis subsp. israelensis have been constructed recently that also delay or prevent mosquito resistance. These recombinants include various strains of B. thuringiensis engineered to produce the binary toxin (Bin) of Lysinibacillus (previously Bacillus) sphaericus combined with Cyt1Aa and other mosquitocidal proteins such as Cry11Aa, and Cry11Ba [23, 24, 35] , or Cry4Ba and Cry2Aa [40] , all of which are significantly more potent than wild-type strains used in current commercial products. In the search for other toxins to add to these recombinants, we identified Cry2Aa owing to its potential activity against mosquito larvae, its structural similarity to Cry11Aa, and especially its potential for synergistic interaction with Cyt1Aa [8, 25] . Here we first demonstrate that purified Cry2Aa and Cyt1Aa formed intermolecular complexes in vitro, suggesting that such interactions could potentially facilitate an enhancement in mosquito larvicidal activity. Furthermore, we show that a combination of Cyt1Aa and Cry2Aa enhances larvicidal activity against a wild-type strain of C. quinquefasciatus, but not against a mutant strain of this species resistant to a combination of Cry4Aa and Cry4Ba.
Materials and Methods

Plasmids, Genes, Bacterial Strains, and Transformation
Plasmids pDBF69, pWF45, and pWF53, which are recombinant constructs of pHT3101 [16] containing, respectively, the cry2Aa, cyt1Aa, and cry11Aa genes, have been previously described [10, 39] . Plasmid pHTC-cry2Aa was generated by cloning the 4 kb SalI/XbaI fragment with the cry2Aa gene in pDBF69 into the same sites in pHTC [23] . All plasmids were amplified in Escherichia coli DH5a and purified with the Wizard Plus Miniprep kit (Promega). The 4Q7 acrystalliferous strain of B. thuringiensis subsp. israelensis (Bacillus Genetic Stock Center at Ohio State University, Columbus, OH, USA) was transformed by electroporation as described by Wu and Federici [39] . Recombinants 4Q7/pDBF69, 4Q7/pWF45, 4Q7/ pWF53, and pHTC-cry2A were selected on Luria-Bertani (LB) agar with, respectively, erythromycin (25 µg/ml) and chloramphenicol (5 µg/ml) at 28 o C. Strain 4Q7/pWF45+pHTC-cry2Aa was selected on LB agar with erythromycin (12.5 µg/ml) and chloramphenicol (5 µg/ml) at 28 o C.
Growth of Bacterial Strains, Microscopy, and Protein Profiles
Recombinant strains 4Q7/pDBF69, 4Q7/pWF45, 4Q7/pWF53, and 4Q7/pWF45+pHTC-cry2Aa were grown on nutrient agar (NA) with appropriate antibiotic selection for 4 days at 28 o C when >95% of cells had sporulated and lysed, as determined by light microscopy with a Zeiss photomicroscope (USA) using a 100× oilimmersion objective. The protein profile of each strain was determined by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) in a 10% acrylamide gel [15] . Spores and crystals were harvested in 500 ml of sterile double-distilled water and collected by centrifugation in a Sorvall RC5C centrifuge at 5,000 rpm, 4 o C for 30 min using the HS-4 rotor. Supernatants were discarded and pellets were resuspended and washed twice in 500 ml of water using the same centrifugation protocol. After the final wash, pellets were frozen at -80 o C for 2 h and lyophilized for 48 h under vacuum using the Virtronic Vacuum with refrigeration set at -60 o C. Powders were stored at room temperature prior to bioassays.
Mosquito Colonies
Two colonies of Culex quinquefasciatus were used for bioassays with various toxin powders. CqSyn, shown in this study to harbor putative receptor(s) for Cry2Aa, is a synthetic colony that was formed in 1995 by pooling multiple field collections and used to establish baseline toxicity values for all the toxin powders and combinations of powders [38] . Cq4AB, shown here to lack putative Cry2Aa receptors, is highly resistant to Cry4Aa+Cry4Ba of Bacillus thuringiensis subsp. israelensis and is also maintained under selection pressure [11] .
Purification of Parasporal Crystalline Inclusions
Crystalline inclusions of Cyt1Aa and Cry2Aa were separated from spores through three successive rounds of purification by centrifugation at 18,000 ×g at 4 o C for 1 h in discontinuous sucrose gradients (79%-72%-67% (w/v)) using the SW27 rotor and the Beckman L7-55 ultracentrifuge. Purified crystals were washed three times in phosphate-buffered saline (PBS, 0.01M phosphate buffer, pH 7.5; 120 mM NaCl) by resuspension and centrifugation as described above.
